Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBMG | AMGN | BMY | GILD | MRNA |
| Company | Cellular Biomedicine | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 19.74 | 312.89 | 44.75 | 64.72 | 120.75 |
| High | 19.75 | 314.89 | 44.97 | 66.20 | 124.90 |
| Low | 19.73 | 309.82 | 44.30 | 64.67 | 116.73 |
| Last | 19.75 | 310.15 | 44.94 | 65.96 | 117.31 |
| Change | unch | -2.71 | +0.20 | +1.38 | -5.38 |
| % Change | unch | -0.87% | +0.45% | +2.14% | -4.39% |
| Volume | 171,900 | 2,611,700 | 8,698,490 | 8,732,800 | 4,236,700 |
| 20-Day Average Volume | 197,580 | 2,930,855 | 14,168,250 | 7,614,355 | 3,404,215 |
| Previous Close | 19.75 | 312.86 | 44.74 | 64.58 | 122.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.27 | 281.61 | 46.01 | 65.99 | 111.95 |
| 20-Day Raw Stochastic | 99.77% | 79.89% | 25.81% | 39.52% | 61.03% |
| 20-Day Relative Strength | 67.50% | 65.95% | 36.90% | 39.82% | 57.48% |
| Weighted Alpha | +21.75 | +34.03 | -34.29 | -19.29 | +3.21 |
| Today's Opinion | 100% Buy | 56% Buy | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 8% Sell | 40% Sell | 56% Sell | 100% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 02/11/21 | -0.37% since 05/03/24 | +2.16% since 05/03/24 | +1.82% since 05/03/24 | -6.15% since 05/03/24 |
| Low | 19.68 on 02/12/21 | 297.52 on 05/06/24 | 43.49 on 05/09/24 | 64.34 on 05/06/24 | 116.73 on 05/10/24 |
| High | 19.75 on 02/18/21 | 314.89 on 05/10/24 | 44.97 on 05/10/24 | 66.20 on 05/10/24 | 125.50 on 05/09/24 |
| 1-Month | |||||
| %Chg | +8.76% since 01/19/21 | +16.40% since 04/10/24 | -10.64% since 04/10/24 | -3.17% since 04/10/24 | +9.49% since 04/10/24 |
| Low | 17.60 on 01/28/21 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 99.30 on 04/22/24 |
| High | 19.75 on 02/18/21 | 322.60 on 05/03/24 | 50.58 on 04/11/24 | 69.03 on 04/11/24 | 128.81 on 05/02/24 |
| 3-Month | |||||
| %Chg | +7.63% since 11/19/20 | +6.54% since 02/09/24 | -9.78% since 02/09/24 | -10.47% since 02/09/24 | +34.21% since 02/09/24 |
| Low | 17.60 on 01/28/21 | 260.68 on 04/19/24 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 84.06 on 02/13/24 |
| High | 19.75 on 02/18/21 | 322.60 on 05/03/24 | 55.03 on 03/13/24 | 76.21 on 03/11/24 | 128.81 on 05/02/24 |
| 6-Month | |||||
| %Chg | +7.57% since 08/19/20 | +16.03% since 11/10/23 | -11.20% since 11/10/23 | -13.12% since 11/10/23 | +67.47% since 11/10/23 |
| Low | 16.98 on 11/06/20 | 260.52 on 11/21/23 | 43.33 on 05/02/24 | 64.33 on 05/03/24 | 67.62 on 11/13/23 |
| High | 19.75 on 02/18/21 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 87.86 on 01/19/24 | 128.81 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 384,691 | 167,829,040 | 90,692,464 | 80,407,072 | 47,019,716 |
| Shares Outstanding, K | 19,478 | 536,435 | 2,027,100 | 1,245,077 | 383,240 |
| Annual Sales | 340,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -49,980,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 30,000 | 7,447,000,000 | 11,865,000,000 | 6,686,000,000 | 167,000,000 |
| Last Quarter Net Income | -17,040,000 | -113,000,000 | -11,911,000,000 | -4,170,000,000 | -1,175,000,000 |
| 60-Month Beta | 1.17 | 0.60 | 0.45 | 0.22 | 1.57 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | -4.40 on 04/25/24 | -1.32 on 04/25/24 | -3.07 on 05/02/24 |
| Latest Earnings Date | 02/26/21 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.50 | 41.59 | 16.11 | 0.00 |